EE200000646A - Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid - Google Patents

Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid

Info

Publication number
EE200000646A
EE200000646A EEP200000646A EEP200000646A EE200000646A EE 200000646 A EE200000646 A EE 200000646A EE P200000646 A EEP200000646 A EE P200000646A EE P200000646 A EEP200000646 A EE P200000646A EE 200000646 A EE200000646 A EE 200000646A
Authority
EE
Estonia
Prior art keywords
lamivudine
zidovudine
pharmaceutical compositions
compositions containing
homogeneous pharmaceutical
Prior art date
Application number
EEP200000646A
Other languages
English (en)
Inventor
Wayne Wood Allen
Currie Robin
Jain Sunil
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200000646A publication Critical patent/EE200000646A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200000646A 1998-04-29 1999-04-26 Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid EE200000646A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809213.3A GB9809213D0 (en) 1998-04-29 1998-04-29 Pharmaceutical compositions
PCT/EP1999/002794 WO1999055372A1 (en) 1998-04-29 1999-04-26 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Publications (1)

Publication Number Publication Date
EE200000646A true EE200000646A (et) 2002-04-15

Family

ID=10831228

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000646A EE200000646A (et) 1998-04-29 1999-04-26 Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid

Country Status (23)

Country Link
EP (1) EP1083932A1 (et)
JP (1) JP2002512979A (et)
KR (1) KR20010043128A (et)
CN (1) CN1411380A (et)
AP (1) AP2000001971A0 (et)
AU (1) AU4135599A (et)
BR (1) BR9910071A (et)
CA (1) CA2330391A1 (et)
EA (1) EA200000997A1 (et)
EE (1) EE200000646A (et)
GB (1) GB9809213D0 (et)
HR (1) HRP20000732A2 (et)
HU (1) HUP0101622A3 (et)
ID (1) ID26955A (et)
IL (1) IL139181A0 (et)
IS (1) IS5675A (et)
NO (1) NO20005418L (et)
NZ (1) NZ507745A (et)
PL (1) PL343710A1 (et)
SK (1) SK16212000A3 (et)
TR (1) TR200003157T2 (et)
WO (1) WO1999055372A1 (et)
ZA (1) ZA200005922B (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AU2002311622A1 (en) * 2002-04-23 2003-11-10 Lupin Limited Long acting compositions comprising zidovudine and lamivudine
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
CN100335125C (zh) * 2003-06-03 2007-09-05 上海现代药物制剂工程研究中心 杀毒抗菌用长效干扰素喷鼻粉剂
WO2006114709A1 (en) * 2005-04-25 2006-11-02 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
US20070059360A1 (en) * 2005-07-29 2007-03-15 Ashish Jaiswal Water-dispersible anti-retroviral pharmaceutical compositions
ES2279707B1 (es) * 2005-11-10 2008-06-01 Combino Pharm, S.L. Formulaciones orales que comprenden 3'-azidonucleosidos.
US20110053884A1 (en) * 2007-10-02 2011-03-03 Schinazi Raymond F Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase
US20110117193A1 (en) * 2008-01-17 2011-05-19 Duquesne University Of The Holy Spirit Antiretroviral drug formulations for treatment of children exposed to hiv/aids
EP3351249A1 (en) * 2010-01-27 2018-07-25 VIIV Healthcare Company Antiviral therapy
CN114010776A (zh) 2010-06-09 2022-02-08 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
CA2866133A1 (en) 2012-03-05 2013-09-12 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
EP2911674A1 (en) 2012-10-23 2015-09-02 Cipla Limited Pharmaceutical antiretroviral composition
HUE066123T2 (hu) * 2013-06-13 2024-07-28 Akebia Therapeutics Inc Készítmények és módszerek anémia kezelésére
CN117618453A (zh) * 2022-08-24 2024-03-01 安徽贝克制药股份有限公司 包含阿巴卡韦、齐多夫定和拉米夫定的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
JP2002512979A (ja) 2002-05-08
HUP0101622A2 (hu) 2002-03-28
WO1999055372A1 (en) 1999-11-04
HRP20000732A2 (en) 2001-02-28
EA200000997A1 (ru) 2001-06-25
NO20005418L (no) 2000-11-29
GB9809213D0 (en) 1998-07-01
AU4135599A (en) 1999-11-16
PL343710A1 (en) 2001-08-27
HUP0101622A3 (en) 2003-09-29
SK16212000A3 (sk) 2001-07-10
IL139181A0 (en) 2001-11-25
EP1083932A1 (en) 2001-03-21
ID26955A (id) 2001-02-22
KR20010043128A (ko) 2001-05-25
BR9910071A (pt) 2000-12-26
NO20005418D0 (no) 2000-10-27
IS5675A (is) 2000-10-20
TR200003157T2 (tr) 2001-01-22
CN1411380A (zh) 2003-04-16
ZA200005922B (en) 2001-10-23
CA2330391A1 (en) 1999-11-04
NZ507745A (en) 2004-07-30
AP2000001971A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
IS5046A (is) Lyfjasamsetningar
ID26982A (id) Komposisi farmasi topiramat
EE200000759A (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
BR9913138B1 (pt) Derivado de quinolin-2-ona substituído com alquinila e composição farcêutica contendo o mesmo
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
ID21491A (id) Komposisi aerosol farmasi
ID29262A (id) Komposisi farmasi
DE69912141D1 (de) Härtbare perfluorelastomerzusammensetzung
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
NO995925D0 (no) Farmasöytiske sammensetninger omfattende cyklodekstriner
DE69918698D1 (de) Härtbare perfluorelastomerzusammensetzung
HUP0101622A3 (en) Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
ID17774A (id) Komposisi farmasi antitrombosis
DE69900561D1 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
DE69915204D1 (de) Stabilisierte Proteinzusammensetzung
DE69818886D1 (de) Tintenzusammensetzung
ID23250A (id) Komposisi paroksetin
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
EE9900175A (et) Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
DE69804313D1 (de) Filmbildende zusammensetzung
IT1298731B1 (it) Composizioni farmaceutiche contenenti complessi di inclusione con melatonina